GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.1588
+0.0050 (3.25%)
Aug 15, 2025, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €24.18 million as of August 15, 2025. Its market cap has decreased by -27.31% in one year.
Market Cap
24.18M
Enterprise Value
40.83M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.16
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 24.18M, a decrease of -90.41%. That is a compound annual growth rate of -22.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 24.18M | -26.85% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | 304.35M | 275.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 121.33B |
| Sanofi | 101.87B |
| Sartorius Stedim Biotech | 17.22B |
| bioMérieux | 14.92B |
| Eurofins Scientific SE | 12.00B |
| Ipsen | 9.18B |
| ABIVAX Société Anonyme | 4.46B |
| Virbac | 2.77B |